Bala Murali Krishna
Specialty Pharma Underperforms S&P 500 For First Time Since 2009
Specialty Pharma Underperforms S&P 500 For First Time Since 2009
Destination-Based Tax Could Trigger Market Sell-Off: Goldman Sachs
'January Effect' To Bring Down Cost Of Dollar Hedges
‘January Effect’ To Bring Down Cost Of Dollar Hedges
'Supportive' Trend For China Metals
‘Supportive’ Trend For China Metals
Goldman: OPEC Oil Cuts Not A Structural Shift
Moody's Cuts Outlook On Italy's Banks To Negative As Bank Failures Loom
Moody’s Cuts Outlook On Italy’s Banks To Negative As Bank Failures Loom
Morgan Launches Global 'Best Business Models' Portfolio – Here Are The Stock Picks
Morgan Launches Global ‘Best Business Models’ Portfolio – Here Are The Stock Picks
BofA: Small Caps Stand To Benefit More Under Trump
BlackRock Big Gainer From Retail "Land Grab"
PwC: Hipsters To Spend Nearly 50% More Than Other Americans This Holiday Season
Moab Partners De-risking Shorts and Credit Hedges Amid Trump Fire Surge
Moody's: Outlook For Global Pharmaceuticals Stable Despite Growing Anger
Moody’s: Outlook For Global Pharmaceuticals Stable Despite Growing Anger

